產(chǎn)品名稱 MK 0364 - Taranabant
產(chǎn)品貨號 Axon 1550 CAS [701977-09-5] MF C27H25ClF3N3O2MW 515.95 Purity: 98% Optical purity: Optically pure Soluble in DMSO Description Potent and selective cannabinoid receptor type 1 (CB1) antagonist and/or inverse agonist References Certificates Categories Extra info TM Fong et al. Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, MK-0364, in rodents.?J. Pharmacol. Exp. Ther. 2007, 321(3), 1013-1022. ? MS Kipnes et al. A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes. Diabetes, Obesity & Metabolism 2010, 12 (6), 517–31. Certificate of Analysis Material Safety Data Sheet Cardiovascular CNS Diabetes & Metabolism Pain & Inflammation CB1 A13 CB1 antagonist/inverse agonist Chemical name N-[(1S,2S)-3-(4-Chloro-phenyl)-2-(3-cyano-phenyl)-1-methyl-propyl]-2-methyl-2-(5-trifluoromethyl-pyridin-2-yloxy)-propionamide Parent CAS No. [701977-09-5] Order Size Unit Price Stock 2 mg €95.00 In Stock
產(chǎn)品價格 現(xiàn)貨詢價,電話:010-67529703
產(chǎn)品規(guī)格
產(chǎn)品品牌 axonmedchem
產(chǎn)品概述
產(chǎn)品詳情

MK 0364 - Taranabant

Based on 14 reference(s) in Google Scholar 8 10 14

Axon 1550

CAS [701977-09-5]

MF C27H25ClF3N3O2
MW 515.95

  • Purity: 98%
  • Optical purity: Optically pure
  • Soluble in DMSO

MK 0364

Description

Potent and selective cannabinoid receptor type 1 (CB1) antagonist and/or inverse agonist
產(chǎn)品資料